Allogene Therapeutics Statistics
Total Valuation
ALLO has a market cap or net worth of $277.35 million. The enterprise value is $91.23 million.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLO has 221.88 million shares outstanding. The number of shares has increased by 22.85% in one year.
| Current Share Class | 221.88M |
| Shares Outstanding | 221.88M |
| Shares Change (YoY) | +22.85% |
| Shares Change (QoQ) | +1.66% |
| Owned by Insiders (%) | 6.76% |
| Owned by Institutions (%) | 66.82% |
| Float | 164.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.80 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.92, with a Debt / Equity ratio of 0.25.
| Current Ratio | 8.92 |
| Quick Ratio | 8.68 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -402.61 |
Financial Efficiency
Return on equity (ROE) is -55.12% and return on invested capital (ROIC) is -28.96%.
| Return on Equity (ROE) | -55.12% |
| Return on Assets (ROA) | -26.98% |
| Return on Invested Capital (ROIC) | -28.96% |
| Return on Capital Employed (ROCE) | -54.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.03M |
| Employee Count | 229 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ALLO has paid $443,000 in taxes.
| Income Tax | 443,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.29% in the last 52 weeks. The beta is 0.36, so ALLO's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -52.29% |
| 50-Day Moving Average | 1.18 |
| 200-Day Moving Average | 1.51 |
| Relative Strength Index (RSI) | 59.09 |
| Average Volume (20 Days) | 2,819,244 |
Short Selling Information
The latest short interest is 20.29 million, so 9.14% of the outstanding shares have been sold short.
| Short Interest | 20.29M |
| Short Previous Month | 19.94M |
| Short % of Shares Out | 9.14% |
| Short % of Float | 12.30% |
| Short Ratio (days to cover) | 6.50 |
Income Statement
| Revenue | n/a |
| Gross Profit | -180.04M |
| Operating Income | -241.16M |
| Pretax Income | -236.47M |
| Net Income | -236.91M |
| EBITDA | -228.52M |
| EBIT | -241.16M |
| Earnings Per Share (EPS) | -$1.11 |
Full Income StatementBalance Sheet
The company has $273.12 million in cash and $87.00 million in debt, giving a net cash position of $186.12 million or $0.84 per share.
| Cash & Cash Equivalents | 273.12M |
| Total Debt | 87.00M |
| Net Cash | 186.12M |
| Net Cash Per Share | $0.84 |
| Equity (Book Value) | 344.56M |
| Book Value Per Share | 1.57 |
| Working Capital | 250.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$172.77 million and capital expenditures -$829,000, giving a free cash flow of -$173.60 million.
| Operating Cash Flow | -172.77M |
| Capital Expenditures | -829,000 |
| Free Cash Flow | -173.60M |
| FCF Per Share | -$0.78 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALLO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.85% |
| Shareholder Yield | n/a |
| Earnings Yield | -85.42% |
| FCF Yield | -62.59% |
Analyst Forecast
The average price target for ALLO is $8.80, which is 604.00% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.80 |
| Price Target Difference | 604.00% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 606.43% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALLO has an Altman Z-Score of -4.69 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.69 |
| Piotroski F-Score | 1 |
